FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022187355> ?p ?o ?g. }

• W2022187355 endingPage "2668" @default.
• W2022187355 startingPage "2668" @default.
• W2022187355 abstract "Lower-than-commonly-prescribed doses of conjugated equine estrogens (CEEs) with medroxyprogesterone acetate (MPA) improve vasomotor symptoms and vaginal atrophy, provide acceptable bleeding and lipid profiles, and afford endometrial protection. This lower-dose therapy's protection against loss of bone mineral density (BMD) associated with menopause has not been thoroughly investigated.To determine the effects of lower doses of CEEs only or CEEs-MPA on spine and hip BMD, total body bone mineral content (BMC), and biochemical markers of bone turnover in postmenopausal women.Two-year randomized, double-blind, placebo-controlled substudy of the Women's Health, Osteoporosis, Progestin, Estrogen trial, conducted at 19 US centers between August 1995 and October 2000.Eight hundred twenty-two healthy postmenopausal women aged 40 to 65 years who were within 4 years of their last menstrual period.Patients were randomly assigned to receive CEEs, 0.625; CEEs, 0.625 and MPA, 2.5; CEEs, 0.45; CEEs, 0.45 and MPA, 2.5; CEEs, 0.45 and MPA, 1.5; CEEs, 0.3; CEEs 0.3 and MPA, 1.5 (all doses in mg/d); or placebo for 2 years. All participants also received elemental calcium at 600 mg/d.Changes from baseline in spine and total hip BMD, total body BMC, and biochemical markers of bone turnover (serum osteocalcin and urinary cross-linked N-telopeptides of type I collagen), assessed at 6-month intervals and compared among treatment groups with a modified intention-to-treat approach.At 24 months, women assigned to all of the active treatment groups had significant gains from baseline (P<.001) in spine and hip BMD and total body BMC (except total body BMC in the group receiving CEEs, 0.3 mg/d). These changes were significantly different from those in the placebo group, in which losses of bone mass in spine and total body were evident over the course of the study (P<.001). The loss in hip BMD from baseline in the placebo group was significant at 18 (P =.02) but not at 24 months (P =.06). Osteocalcin and N-telopeptides of type I collagen were significantly reduced from baseline (P<.001) for all active treatment groups at all time points; no changes were found for the placebo group. For women treated with CEEs alone, the gains in spine BMD for the group taking CEEs, 0.625 mg/d, were significantly higher than those of the group taking CEEs, 0.3 mg/d (P =.02), but not the group treated with CEEs, 0.45 mg/d (P =.48).Doses of CEEs or CEEs-MPA lower than 0.625 mg/d effectively increase BMD and BMC in early postmenopausal women." @default.
• W2022187355 created "2016-06-24" @default.
• W2022187355 creator A5072325890 @default.
• W2022187355 date "2002-05-22" @default.
• W2022187355 modified "2023-09-27" @default.
• W2022187355 title "Effect of Lower Doses of Conjugated Equine Estrogens With and Without Medroxyprogesterone Acetate on Bone in Early Postmenopausal Women" @default.
• W2022187355 cites W1979201224 @default.
• W2022187355 cites W1980370066 @default.
• W2022187355 cites W1986009920 @default.
• W2022187355 cites W2002535656 @default.
• W2022187355 cites W2002924549 @default.
• W2022187355 cites W2004236425 @default.
• W2022187355 cites W2004302812 @default.
• W2022187355 cites W2028655493 @default.
• W2022187355 cites W2031570803 @default.
• W2022187355 cites W2048941578 @default.
• W2022187355 cites W2056885783 @default.
• W2022187355 cites W2065134350 @default.
• W2022187355 cites W2078406992 @default.
• W2022187355 cites W2094838099 @default.
• W2022187355 cites W2114724335 @default.
• W2022187355 cites W2116858560 @default.
• W2022187355 cites W2132373390 @default.
• W2022187355 cites W2134137902 @default.
• W2022187355 cites W2158065918 @default.
• W2022187355 cites W2159416358 @default.
• W2022187355 cites W2335240422 @default.
• W2022187355 cites W2403605878 @default.
• W2022187355 cites W2616697655 @default.
• W2022187355 cites W44375275 @default.
• W2022187355 doi "https://doi.org/10.1001/jama.287.20.2668" @default.
• W2022187355 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12020302" @default.
• W2022187355 hasPublicationYear "2002" @default.
• W2022187355 type Work @default.
• W2022187355 sameAs 2022187355 @default.
• W2022187355 citedByCount "332" @default.
• W2022187355 countsByYear W20221873552012 @default.
• W2022187355 countsByYear W20221873552013 @default.
• W2022187355 countsByYear W20221873552014 @default.
• W2022187355 countsByYear W20221873552015 @default.
• W2022187355 countsByYear W20221873552016 @default.
• W2022187355 countsByYear W20221873552017 @default.
• W2022187355 countsByYear W20221873552018 @default.
• W2022187355 countsByYear W20221873552019 @default.
• W2022187355 countsByYear W20221873552020 @default.
• W2022187355 countsByYear W20221873552021 @default.
• W2022187355 countsByYear W20221873552022 @default.
• W2022187355 countsByYear W20221873552023 @default.
• W2022187355 crossrefType "journal-article" @default.
• W2022187355 hasAuthorship W2022187355A5072325890 @default.
• W2022187355 hasBestOaLocation W20221873551 @default.
• W2022187355 hasConcept C126322002 @default.
• W2022187355 hasConcept C126894567 @default.
• W2022187355 hasConcept C131075544 @default.
• W2022187355 hasConcept C134018914 @default.
• W2022187355 hasConcept C142724271 @default.
• W2022187355 hasConcept C160160445 @default.
• W2022187355 hasConcept C170033053 @default.
• W2022187355 hasConcept C181199279 @default.
• W2022187355 hasConcept C185592680 @default.
• W2022187355 hasConcept C204787440 @default.
• W2022187355 hasConcept C27081682 @default.
• W2022187355 hasConcept C2776306185 @default.
• W2022187355 hasConcept C2776541429 @default.
• W2022187355 hasConcept C2776886416 @default.
• W2022187355 hasConcept C2776917545 @default.
• W2022187355 hasConcept C2777164284 @default.
• W2022187355 hasConcept C2778562196 @default.
• W2022187355 hasConcept C2779279991 @default.
• W2022187355 hasConcept C2780159708 @default.
• W2022187355 hasConcept C29456083 @default.
• W2022187355 hasConcept C55493867 @default.
• W2022187355 hasConcept C71924100 @default.
• W2022187355 hasConceptScore W2022187355C126322002 @default.
• W2022187355 hasConceptScore W2022187355C126894567 @default.
• W2022187355 hasConceptScore W2022187355C131075544 @default.
• W2022187355 hasConceptScore W2022187355C134018914 @default.
• W2022187355 hasConceptScore W2022187355C142724271 @default.
• W2022187355 hasConceptScore W2022187355C160160445 @default.
• W2022187355 hasConceptScore W2022187355C170033053 @default.
• W2022187355 hasConceptScore W2022187355C181199279 @default.
• W2022187355 hasConceptScore W2022187355C185592680 @default.
• W2022187355 hasConceptScore W2022187355C204787440 @default.
• W2022187355 hasConceptScore W2022187355C27081682 @default.
• W2022187355 hasConceptScore W2022187355C2776306185 @default.
• W2022187355 hasConceptScore W2022187355C2776541429 @default.
• W2022187355 hasConceptScore W2022187355C2776886416 @default.
• W2022187355 hasConceptScore W2022187355C2776917545 @default.
• W2022187355 hasConceptScore W2022187355C2777164284 @default.
• W2022187355 hasConceptScore W2022187355C2778562196 @default.
• W2022187355 hasConceptScore W2022187355C2779279991 @default.
• W2022187355 hasConceptScore W2022187355C2780159708 @default.
• W2022187355 hasConceptScore W2022187355C29456083 @default.
• W2022187355 hasConceptScore W2022187355C55493867 @default.
• W2022187355 hasConceptScore W2022187355C71924100 @default.
• W2022187355 hasIssue "20" @default.
• W2022187355 hasLocation W20221873551 @default.
• W2022187355 hasLocation W20221873552 @default.

• next